Linda Liao

Linda Liao has over 25 years of experience in the biotechnology and pharmaceutical industries, currently serving as a Research Associate at the Ontario Institute for Cancer Research since November 2011. Previous roles include Research Technician in Transformative Pathology and Diagnostic Development, a Scientist in Drug Discovery and Preclinical at Transition Therapeutics Inc., and various scientist and research associate positions at Protana, Maxxam BioDiscoveries, Allelix Inc., and Cangene Corporation. Educational qualifications include a Bachelor of Science in Microbiology from the University of Guelph, along with a significant background in pharmacology, cell biology, and assay development.